Breathe Easier With Precise, Step-Wise Care

Spirometry, trigger control, and guideline-based inhaler plans for lasting relief

Book Respiratory Consultation

35%

Fewer ER Visits

With inhaler-technique training and written action plans at 6 months

24 hrs

Report Turnaround

Same-day spirometry and chest X-ray when indicated

90%

Correct Technique

Patients demonstrate proper inhaler use after education

When to Consult

•Night cough, wheeze, or chest tightness more than twice a week
•Shortness of breath with routine activity or exercise
•Seasonal sneezing, runny/blocked nose, or itchy eyes with breathing issues
•Recurrent bronchitis or pneumonias in the last year
•Persistent cough >3 weeks after a viral illness
•Frequent need for rescue inhaler or nebuliser

Understanding Respiratory Illness in the Indian Context

Hyderabad’s dust, construction, incense, and seasonal infections make breathing issues common. At Ajuda Hospitals, we focus on objective testing (spirometry), correct device choice, and trigger control to prevent flares—especially during winter smog and viral surges.

When to Consult Our Respiratory Specialists

⚠️ Seek urgent care for:

✓ Severe breathlessness at rest or bluish lips
✓ Chest pain, confusion, or fainting
✓ High fever with chills and fast breathing

Book a routine visit for persistent cough/wheeze, exercise breathlessness, or seasonal allergies that disrupt sleep or work.

Our Diagnostic Approach

Spirometry With Reversibility

Objective confirmation and staging; repeat per standards.

Allergy & Trigger Workup

History, environment review, and selective tests.

Imaging/Biomarkers

Chest X-ray; FeNO where available to tailor steroids.

Technique & Comorbidity Review

Device fit, spacer use, and rhinitis/GERD checks to close control gaps.

Treatment Pathways

From everyday trigger control to step-wise controller therapy, acute flare management, immunotherapy where appropriate, and tele-follow-ups—your plan targets stable control and fewer emergencies.

What to Expect: Your Care Journey

First visit: history, spirometry, device teaching → 2–4 weeks: technique review and dose adjustments → 6–8 weeks: control check and step-down consideration → Seasonal action plans and quarterly maintenance.

Technology & Innovation

Spirometry and (where available) FeNO integrate with EMR dashboards. Video coaching ensures correct technique; peak-flow logs flag early deterioration.

Preventing Complications

Good control reduces ER visits, hospitalisations, and work/school loss. Vaccinations and early treatment of infections prevent severe flares.

Why Ajuda for Respiratory Care?

📊 Objective Testing

Spirometry/FeNO guide precise dosing and step-downs.

🧭 Personalised Action Plans

Written plans, device choice, and trigger control you can follow.

📱 Tele Follow-ups

WhatsApp reviews keep momentum and prevent flares.

Take the First Step

Call 9010550550 or book online for spirometry and a tailored action plan today.

Diagnosis Approach

Spirometry With Reversibility

Pre/post bronchodilator spirometry to confirm airflow limitation and response; repeatability ensured by ATS/ERS standards.

Allergy & Trigger Evaluation

History-first approach; skin-prick/IgE tests selectively; assess dust, mites, pets, incense, workplace exposures.

Imaging & Biomarkers (Selective)

Chest X-ray for red flags; consider FeNO where available to gauge eosinophilic inflammation and tailor inhaled steroids.

Comorbidity & Technique Check

Screen rhinitis/GERD/OSA; verify device choice (MDI/DPI/neb), spacer use, and adherence.

Treatment Options

Trigger Control & Lifestyle

Dust-mite covers, wet-mopping, mask use during sweeping, smoke avoidance; saline nasal rinses and sleep hygiene.

Cuts symptom days and rescue use by ~20–30%

Ongoing with monthly tweaks initially

Controller Therapy (Step-Wise)

ICS ± LABA per guideline steps; add LTRA for allergic phenotype. Nasal steroids/antihistamines for rhinitis.

Exacerbations drop by ~30–45% with adherence

Reassess every 6–8 weeks; step down when stable

Acute Exacerbation Pathway

Nebulised bronchodilators, short steroid course, antibiotics only when bacterial infection suspected.

Rapid relief within hours; prevents admissions in mild–moderate flares

48–72 hrs stabilisation, then plan review

Allergen Immunotherapy (Select)

For refractory allergic rhinitis/asthma; coordinate with ENT/allergy for SCIT/SLIT protocols.

Reduces symptom/medication scores over 6–12 months

Long-term; staged escalation

Special Populations

Pregnancy-safe inhaled regimens; elderly with COPD overlap; athlete/exercise-induced bronchospasm.

Maintains control with minimal side effects

Condition-specific follow-up cadence

Telemedicine & Action Plan

WhatsApp check-ins, inhaler video verification, and peak-flow logs for early flare detection.

Improves adherence by ~25–30% and cuts urgent visits

First 3 months intensive; quarterly thereafter

Expected Outcomes

Treatment Timeline

2–4 Weeks

Night symptoms reduce; better exercise tolerance

6–8 Weeks

Stable control with fewer rescue puffs; fewer sick days

3–6 Months

ER visits and exacerbations down; step-down considered

1 Year+

Sustained control with seasonal action plans

Success Metrics

ACT score improvement ≥3 points
Rescue inhaler use <2 times/week
Zero admissions for most controlled patients

Breathe Easier — Start Today

Emergency

9010550550

contact@ajudahospitals.in

Related Services

Viral Fevers

Common trigger for asthma flares

Pneumonia

Evaluate when fever, chest pain, or breathlessness escalate

Adult Vaccinations

Flu and pneumococcal shots lower flare risk